SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001185185-23-000265
Filing Date
2023-03-28
Accepted
2023-03-28 11:16:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D chopra20230328_sc13d.htm SC 13D 32161
  Complete submission text file 0001185185-23-000265.txt   33632
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Subject) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-50211 | Film No.: 23767184
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACERAGEN, INC. 15 TW ALEXANDER DRIVE DURHAM NC 27709
Business Address
Chopra Atul (Filed by) CIK: 0001946240 (see all company filings)

Type: SC 13D